Некоторые патогенетические механизмы кожных изменений у больных Сovid-19

ПРЕПРИНТ

Эта статья является препринтом и не была отрецензирована.
О результатах, изложенных в препринтах, не следует сообщать в СМИ как о проверенной информации.

Евдокимов Е. Ю.,

Понежева Ж. Б.,

Усенко Д. В.,

Горелова Е. А.,

Сундуков А. В.,

Свечникова Е. В.,

Малеев В. В.,

Акимкин В. Г.

2020-08-07

https://doi.org/10.21055/preprints-3111773

В статье рассматриваются патогенетические аспекты поражения кожи при инфекции COVID-19, а также обсуждается роль повреждения целостности кожного покрова, вследствие различных воспалительных изменений, для проникновения вируса SARS-CoV-2.

Ссылка для цитирования:

Евдокимов Е. Ю., Понежева Ж. Б., Усенко Д. В., Горелова Е. А., Сундуков А. В., Свечникова Е. В., Малеев В. В., Акимкин В. Г. 2020. Некоторые патогенетические механизмы кожных изменений у больных Сovid-19. COVID19-PREPRINTS.MICROBE.RU. https://doi.org/10.21055/preprints-3111773

Список литературы

1. https://coronavirus-monitor.ru

2. Wei-jie Guan et all. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med 2020; 382:1708-1720 DOI: 10.1056 / NEJMoa2002032

3. Recalcati, S. (2020), Cutaneous manifestations in COVID 19: a first perspective. J Eur Acad Dermatol Venereol, 34: e212-e213. doi:10.1111/jdv.16387.

4. Estébanez, A., Pérez, Santiago, L., Silva, E., Guillen, Climent, S., García, Vázquez, A. and Ramón, M. (2020), Cutaneous manifestations in COVID 19: a new contribution. J Eur Acad Dermatol Venereol, 34: e250-e251. doi:10.1111/jdv.16474

5. Alramthan A, Aldaraji W. A Case of COVID-19 Presenting in Clinical Picture Resembling Chilblains Disease. First report from the Middle East. Clin Exp Dermatol. 17 April 2020 https://doi.org/10.1111/ced.14243.

6. Tang K, Wang Y, Zhang H, Zheng Q, Fang R, Sun Q. Cutaneous manifestations of the Coronavirus Disease 2019 (COVID-19): A brief review [published online ahead of print, 2020 May 7]. Dermatol Ther. 2020;e13528. doi:10.1111/dth.13528.

7. Wollina U, Karadağ AS, Rowland-Payne C, Chiriac A, Lotti T. Cutaneous signs in COVID-19 patients: A review [published online ahead of print, 2020 May 10]. Dermatol Ther. 2020;e13549. doi:10.1111/dth.13549

8. C. Galván Casas A. Català G. Carretero Hernández P. Rodríguez-Jiménez D. Fernández-Nieto A. Rodríguez-Villa Lario I. Navarro Fernández R. Ruiz-Villaverde et all. Classification of the cutaneous manifestations of COVID -19: a rapid prospective nationwide consensus study in Spain with 375 cases. First published: 29 April 2020 https://doi.org/10.1111/bjd.19163

9. Walls AC, Park YJ, Tortorici MA, Wall A, McGuire AT, Veesler D. Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein. Cell. 2020 doi: 10.1016/j.cell.2020.02.058.

10. Абатуров А.Е., Агафонова Е.А., Кривуша Е.Л., & Никулина А.А. (2020). ПАТОГЕНЕЗ COVID-19. Здоровье ребенка, 15 (2), 133-144.

11. Gianotti R, Veraldi S, Recalcati S, et al. Cutaneous Clinico-Pathological Findings in three COVID-19-Positive Patients Observed in the Metropolitan Area of Milan, Italy. Acta Derm Venereol. 2020;100(8):adv00124. Published 2020 Apr 23. doi:10.2340/00015555-3490.

12. Xu, H., Zhong, L., Deng, J. et al. High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa. Int J Oral Sci 12, 8 (2020). https://doi.org/10.1038/s41368-020-0074-x

13. Xue X, Mi Z, Wang Z, Pang Z, Liu H, Zhang F. High Expression of ACE2 on Keratinocytes Reveals Skin as a Potential Target for SARS-CoV-2 [published online ahead of print, 2020 May 23]. J Invest Dermatol. 2020;S0022-202X(20)31602-X. doi:10.1016/j.jid.2020.05.087

14. Дубенко О.Е., Костюковская А.Е., Костюковский С.Л. (2014). Полиморфизм гена ангиотензинпревращающего фермента и уровень ангиотензина II при остром инсульте. Международный неврологический журнал, (4 (66)), 32-38.

15. Li Y, Zhou W, Yang L, You R. Physiological and pathological regulation of ACE2, the SARS-CoV-2 receptor. Pharmacol Res. 2020;157:104833. doi:10.1016/j.phrs.2020.104833

16. Hennighausen L, Lee HK. Activation of the SARS-CoV-2 receptor Ace2 by cytokines through pan JAK-STAT enhancers. Preprint. bioRxiv. 2020;2020.05.11.089045. Published 2020 May 11. doi:10.1101/2020.05.11.089045

17. Rochman Y, Kashyap M, Robinson GW, et al. Thymic stromal lymphopoietin-mediated STAT5 phosphorylation via kinases JAK1 and JAK2 reveals a key difference from IL-7-induced signaling. Proc Natl Acad Sci U S A. 2010;107(45):19455-19460. doi:10.1073/pnas.1008271107

18. Zhong J, Sharma J, Raju R, et al. TSLP signaling pathway map: a platform for analysis of TSLP-mediated signaling. Database (Oxford). 2014;2014:bau007. Published 2014 Feb 25. doi:10.1093/database/bau007

19. Harada M, Hirota T, Jodo AI, et al. Thymic stromal lymphopoietin gene promoter polymorphisms are associated with susceptibility to bronchial asthma. Am J Respir Cell Mol Biol. 2011;44(6):787-793. doi:10.1165/rcmb.2009-0418OC

20. Zsolt Dajnoki, Gabriella Béke, Anikó Kapitány, Gábor Mócsai, Krisztián Gáspár, Ralph Rüh, et all. Sebaceous Gland-Rich Skin Is Characterized by TSLP Expression and Distinct Immune Surveillance Which Is Disturbed in Rosacea. Journal of Investigative Dermatology, Volume 137, Issue 5, May 2017, Pages 997. https://doi.org/10.1016/j.jid.2016.12.025

21. Suwarsa O, Dharmadji HP, Sutedja E, et al. Skin tissue expression and serum level of thymic stromal lymphopoietin in patients with psoriasis vulgaris. Dermatol Reports. 2019;11(1):8006. Published 2019 Jun 20. doi:10.4081/dr.2019.8006

22. Jariwala SP, Abrams E, Benson A, Fodeman J, Zheng T. The role of thymic stromal lymphopoietin in the immunopathogenesis of atopic dermatitis. Clin Exp Allergy. 2011;41(11):1515-1520. doi:10.1111/j.1365-2222.2011.03797.x

23. Lee HC, Headley MB, Loo YM, et al. Thymic stromal lymphopoietin is induced by respiratory syncytial virus-infected airway epithelial cells and promotes a type 2 response to infection. J Allergy Clin Immunol. 2012;130(5):1187-1196.e5. doi:10.1016/j.jaci.2012.07.031

24. Xie Y, Takai T, Chen X, Okumura K, Ogawa H. Long TSLP transcript expression and release of TSLP induced by TLR ligands and cytokines in human keratinocytes. J Dermatol Sci. 2012;66(3):233-237. doi:10.1016/j.jdermsci.2012.03.007

ПРЕПРИНТ

ИНФОРМАЦИЯ О ПРЕПРИНТЕ